tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Phil Nadeau, 144 are a BUY (92.31%), 12 are a HOLD (7.69%).
Analyst Phil Nadeau, currently employed at TD COWEN, carries an average stock price target met ratio of 69.58% that have a potential upside of 35.16% achieved within 463 days.
Phil Nadeau’s has documented 307 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 04-Aug-2026.
Analyst best performing recommendations are on AURA (AURA BIOSCIENCES).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/4/2020. The price target of $275 was fulfilled within 5 days with a profit of $80.63 (22.67%) receiving and performance score of 45.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
5 years 3 months 10 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
5 years 8 months 14 days ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
6 years 4 months 21 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
6 years 4 months 21 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
6 years 11 months 6 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
Which stock is Phil Nadeau most bullish on?
Which stock is Phil Nadeau most reserved on?
What Year was the first public recommendation made by Phil Nadeau?
